Not sure it'd be that easy for them. Probably 30-40% or so of shares are tightly held by BOT people and/or their associates. Whilst BOT have made it clear that they would consider selling "for the right price", Matt Callaghan has also made it clear he thinks BOT can become a major derma company, particularly with acne, rosacea and anti-microbial still up its sleeve to further develop with non-dilutive funding (e.g. Sofdra sales). So I expect BP will have to pay through the nose, and I'm not sure they're at that point yet until sales are demonstrated.
BOT - Anything but charting, page-9390
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.015(4.23%) |
Mkt cap ! $660.6M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.5¢ | 36.0¢ | $2.615M | 7.147M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 330989 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 152234 | 8 |
View Market Depth
| Last trade - 15.05pm 24/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |